Farhad Vesuna

Farhad Vesuna

Auto-generated profile, based on publicly available information

Farhad Vesuna

Department of Radiology and Radiological Science, Johns Hopkins University School of Medicine, Baltimore, MD, USA

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 July 2009 in Oncogene
Verified
Journal Article
Open access
PDF file
NSN J Sullivan
N J Sullivan
ASA K Sasser
A K Sasser
AAA E Axel
A E Axel
FVF Vesuna
F Vesuna
VRV Raman
V Raman
BHB M Hall
B M Hall
Breast tumor interleukin-6 (IL-6) levels increase with tumor grade, and elevated serum IL-6 correlates with poor breast cancer patient survival. Epithelial–mesenchymal transition (EMT) phenotypes such as impaired E-cadherin expression or aberrant Vimentin induction are associated with enhanced metastasis and unfavorable clinical outcome in breast cancer. Despite this fact, few tumor microenvironment-derived extracellular signaling factors capable of provoking such a phenotypic transition have been identified. In this study, we showed that IL-6 promoted E-cadherin repression among a panel of estrogen receptor-α-positive human breast cancer cells. Furthermore, ectopic stable IL-6 expressing MCF-7 breast adenocarcinoma cells (MCF-7IL−6) exhibited an EMT phenotype characterized by impaired E-cadherin expression and induction of Vimentin, N-cadherin, Snail and Twist. MCF-7IL−6 cells formed xenograft tumors that displayed loss of E-cadherin, robust Vimentin induction, increased proliferative indices, advanced tumor grade and undifferentiated histology. Finally, we showed aberrant IL-6 production and STAT3 activation in MCF-7 cells that constitutively express Twist, a metastatic regulator and direct transcriptional repressor of E-cadherin. To our knowledge, this is the first study that shows IL-6 as an inducer of an EMT phenotype in breast cancer cells and implicates its potential to promote breast cancer metastasis.

1 March 2008 in Biochemical and Biophysical Research Communications
Verified
Journal Article
Closed access
FVFarhad Vesuna
Farhad Vesuna
PDPaul van Diest
Paul van Diest
JCJi Hshiung Chen
Ji Hshiung Chen
VRVenu Raman
Venu Raman

1 December 2005 in Cancer Research
Verified
Journal Article
Closed access
PDF file
YMYelena Mironchik
Yelena Mironchik
PWPaul T. Winnard
Paul T. Winnard
FVFarhad Vesuna
Farhad Vesuna
YKYoshinori Kato
Yoshinori Kato
FWFlonne Wildes
Flonne Wildes
VRVenu Raman
Venu Raman
Aggressive cancer phenotypes are a manifestation of many different genetic alterations that promote rapid proliferation and metastasis. In this study, we show that stable overexpression of Twist in a breast cancer cell line, MCF-7, altered its morphology to a fibroblastic-like phenotype, which exhibited protein markers representative of a mesenchymal transformation. In addition, it was observed that MCF-7/Twist cells had increased vascular endothelial growth factor (VEGF) synthesis when compared with empty vector control cells. The functional changes induced by VEGF in vivo were analyzed by functional magnetic resonance imaging (MRI) of MCF-7/Twist-xenografted tumors. MRI showed that MCF-7/Twist tumors exhibited higher vascular volume and vascular permeability in vivo than the MCF-7/vector control xenografts. Moreover, elevated expression of Twist in breast tumor samples obtained from patients correlated strongly with high-grade invasive carcinomas and with chromosome instability, particularly gains of chromosomes 1 and 7. Taken together, these results show that Twist overexpression in breast cancer cells can induce angiogenesis, correlates with chromosomal instability, and promotes an epithelial-mesenchymal-like transition that is pivotal for the transformation into an aggressive breast cancer phenotype.

27 March 2015 in EMBO Molecular Medicine
Verified
Journal Article
Open access
PDF file
GBGuus Bol
Guus Bol
FVFarhad Vesuna
Farhad Vesuna
MXMin Xie
Min Xie
JZJing Zeng
Jing Zeng
KAKhaled Aziz
Khaled Aziz
VRVenu Raman
Venu Raman
Lung cancer is the most common malignancy worldwide and is a focus for developing targeted therapies due to its refractory nature to current treatment. We identified a RNA helicase, DDX3, which is overexpressed in many cancer types including lung cancer and is associated with lower survival in lung cancer patients. We designed a first‐in‐class small molecule inhibitor, RK‐33, which binds to DDX3 and abrogates its activity. Inhibition of DDX3 by RK‐33 caused G1 cell cycle arrest, induced apoptosis, and promoted radiation sensitization in DDX3‐overexpressing cells. Importantly, RK‐33 in combination with radiation induced tumor regression in multiple mouse models of lung cancer. Mechanistically, loss of DDX3 function either by shRNA or by RK‐33 impaired Wnt signaling through disruption of the DDX3–β‐catenin axis and inhibited non‐homologous end joining—the major DNA repair pathway in mammalian somatic cells. Overall, inhibition of DDX3 by RK‐33 promotes tumor regression, thus providing a compelling argument to develop DDX3 inhibitors for lung cancer therapy.

1 December 2009 in Neoplasia
Verified
Journal Article
Open access
PDF file
FVFarhad Vesuna
Farhad Vesuna
ALAla Lisok
Ala Lisok
BKBrian Kimble
Brian Kimble
VRVenu Raman
Venu Raman
Neoplasia publishes the results of novel investigations in all areas of oncology research.

11 February 2008 in Oncogene
Verified
Journal Article
Open access
PDF file
MBM Botlagunta
M Botlagunta
FVF Vesuna
F Vesuna
YMY Mironchik
Y Mironchik
ARA Raman
A Raman
ALA Lisok
A Lisok
VRVenu Raman
Venu Raman
Benzo[a]pyrene diol epoxide (BPDE), the active metabolite of benzo[a]pyrene present in tobacco smoke, is a major cancer-causing compound. To evaluate the effects of BPDE on human breast epithelial cells, we exposed an immortalized human breast cell line, MCF 10A, to BPDE and characterized the gene expression pattern. Of the differential genes expressed, we found consistent activation of DDX3, a member of the DEAD box RNA helicase family. Overexpression of DDX3 in MCF 10A cells induced an epithelial-mesenchymal-like transformation, exhibited increased motility and invasive properties, and formed colonies in soft-agar assays. Besides the altered phenotype, MCF 10A-DDX3 cells repressed E-cadherin expression as demonstrated by both immunoblots and by E-cadherin promoter-reporter assays. In addition, an in vivo association of DDX3 and the E-cadherin promoter was demonstrated by chromatin immunoprecipitation assays. Collectively, these results demonstrate that the activation of DDX3 by BPDE, can promote growth, proliferation and neoplastic transformation of breast epithelial cells.